HSV-tk/GCV Gene Therapy Mediated by EBV-LMP1 for EBV-associated Cancer

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/1756-9966-27-42
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HSV Vector Cytotoxicity Is Inversely Correlated With Effective TK/GCV Suicide Gene Therapy of Rat Gliosarcoma

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Synergistic Effect of Resveratrol and HSV-TK/GCV Therapy on Murine Hepatoma Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

EBV-Associated Malignancies

The Open Infectious Diseases Journal
2010English

mTORC2-mediated PDHE1α Nuclear Translocation Links EBV-LMP1 Reprogrammed Glucose Metabolism to Cancer Metastasis in Nasopharyngeal Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Virally Targeted Therapies for EBV-associated Malignancies

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Lack of Expression of the Epstein-Barr Virus (EBV) Gene Products, EBERs, EBNA1, LMP1, and LMP2A, in Breast Cancer Cells

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2002English

HSV-tk Gene Therapy for Human Renal Cell Carcinoma in Nude Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2001English

Characterization of Variants in the Promoter of BZLF1 Gene of EBV in Nonmalignant EBV-associated Diseases in Chinese Children

Virology Journal
VirologyInfectious Diseases
2010English

EBV-LMP1-targeted DNAzyme Induces DNA Damage and Causes Cell Cycle Arrest in LMP1-positive Nasopharyngeal Carcinoma Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy